Identifying Molecular Targets in Bladder Cancer
Author Information
Author(s): Sánchez-Carbayo M, Cordon-Cardo C
Primary Institution: Memorial Sloan-Kettering Cancer Center
Hypothesis
The study aims to explore the use of array technologies to identify molecular targets associated with bladder cancer.
Conclusion
High-throughput array technologies can significantly enhance the identification of molecular targets and improve treatment strategies for bladder cancer.
Supporting Evidence
- Microarrays can measure hundreds or thousands of genes in a single experiment.
- Array technologies can help identify molecular targets associated with bladder cancer.
- Gene expression profiling can classify bladder tumors into clinically relevant subtypes.
- Studies have shown that specific gene expression patterns correlate with tumor stage and grade.
- High-throughput technologies are changing the approach to cancer diagnosis and treatment.
Takeaway
Scientists are using special technology to look at many genes at once to find out what causes bladder cancer and how to treat it better.
Methodology
The study utilized DNA microarrays to analyze gene expression patterns in bladder cancer tissues and cell lines.
Limitations
The study is limited by the relatively small number of studies using DNA microarrays for bladder cancer.
Participant Demographics
The study involved analysis of 36 normal and 29 bladder tumor biopsies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website